Riskpilot← Back to searchSign inGet full accessRefai Medinvest AB
ABActiveOrg 5592290968Ugglevägen 31Hospital activities · NACE 8610Est. 20191 employees
Revenue 2024
SEK 369K
-9% vs 2023
EBITDA margin
69.7%
-28% vs 2023
Equity ratio
55.3%
Financial strength
Net profit 2024
SEK 205K
-21% vs 2023
| Revenue | SEK 369K | -9% |
| EBITDA | SEK 257K | -28% |
| Net profit | SEK 205K | -21% |
| Total assets | SEK 462K | -11% |
| Equity | SEK 255K | -18% |
| Employees | 1 | — |
Legal name
Refai Medinvest AB
Org number
5592290968
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
30 november 2019
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget bedriver konsultläkartjänster inom medicinsk vård framförallt inom anestesi- och intensivvård. Bolaget bedriver även bloggverksamhet i form av ett nyhetsbrev.
Address
Ugglevägen 31
Email
rami.refai@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 564 | 531 | 396 | 403 | 369 |
| Staff expenses | — | — | −12 | −7 | −92 |
| EBITDA | 432 | 60 | 259 | 355 | 257 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 432 | 60 | 259 | 355 | 257 |
| Net financials | — | −8 | −14 | −27 | 1 |
| Profit before tax | 433 | 69 | 245 | 327 | 257 |
| Tax | −93 | −13 | −50 | −67 | −53 |
| Net profit | 340 | 56 | 194 | 260 | 205 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 637 | 364 | 391 | 519 | 462 |
| Equity | 390 | 106 | 245 | 311 | 255 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 247 | 258 | 147 | 209 | 207 |
| Total debt | 247 | 258 | 147 | 209 | 207 |
EBITDA margin
69.7%
This company
15.8%
Market median
+341% vs market
20202024
Equity ratio
55.3%
This company
38.2%
Market median
+45% vs market
20202024
Return on equity
80.2%
This company
18.4%
Market median
+336% vs market
20202024
Net profit margin
55.6%
This company
8.1%
Market median
+586% vs market
20202024
Asset turnover
0.80×
This company
1.12×
Market median
-29% vs market
20202024
Debt / equity
0.81×
This company
0.62×
Market median
+31% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-11-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Refai Medinvest AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Matilda Elin Refai | Deputy Board Member | 0 companies |
| Rami Mohammed Jonas Refai | Board of Directors | 0 companies |